Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
2(40%)
Results Posted
33%(1 trials)

Phase Distribution

Ph phase_3
1
20%
Ph not_applicable
2
40%
Ph phase_2
1
20%

Phase Distribution

0

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
Phase 3Large-scale testing
1(25.0%)
N/ANon-phased studies
2(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

5

all time

Status Distribution
Active(2)
Completed(3)

Detailed Status

Completed3
Recruiting2

Development Timeline

Analytics

Development Status

Total Trials
5
Active
2
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 21 (25.0%)
Phase 31 (25.0%)
N/A2 (50.0%)

Trials by Status

recruiting240%
completed360%

Recent Activity

2 active trials
Showing 5 of 5
completednot_applicable

Changes in Eosinophil Cationic Protein and Sputum Eosinophils Following Allergen Immunotherapy

NCT07694947
recruitingphase_3

Efficacy and Safety of SLIT in Patients With Rhinitis/RC With/Without Mild-moderate Asthma, Due to Dpt and/or Df

NCT07348302
recruiting

Long Term Effect of AIT in Children

NCT06421415
completednot_applicable

Efficacy of Sublingual Versus Subcutaneous Allergen Immunotherapy in Patients With Bronchial Asthma

NCT05786638
completedphase_2

A Novel Biologic Therapy for Perennial Allergic Rhinitis

NCT03360071

Clinical Trials (5)

Showing 5 of 5 trials
NCT07694947Not Applicable

Changes in Eosinophil Cationic Protein and Sputum Eosinophils Following Allergen Immunotherapy

Completed
NCT07348302Phase 3

Efficacy and Safety of SLIT in Patients With Rhinitis/RC With/Without Mild-moderate Asthma, Due to Dpt and/or Df

Recruiting
NCT06421415

Long Term Effect of AIT in Children

Recruiting
NCT05786638Not Applicable

Efficacy of Sublingual Versus Subcutaneous Allergen Immunotherapy in Patients With Bronchial Asthma

Completed
NCT03360071Phase 2

A Novel Biologic Therapy for Perennial Allergic Rhinitis

Completed

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5